[ad_1] News 25 October 2023 Freshfields is advising Roivant Sciences Ltd. (Nasdaq: ROIV) on the sale of Telavant, a Roivant company owned by Roivant and Pfizer, to Roche for…
Tag: Roivant
Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
[ad_1] Updated Oct. 23, 2023 6:55 am ET Roche Holding has agreed to buy the developer of a bowel-disease treatment from Roivant Sciences, a company started by Republican presidential candidate…
Collecting Pharma’s Scraps Can Pay Off for This Biotech
[ad_1] Markets Heard on the Street Roivant has built a unique model that allows it to benefit from big pharma’s need to reduce R&D spending [ad_2] Source link